ReviewFrontiers in psychiatry2023

Selecting the appropriate hurdles and endpoints for pentilludin, a novel antiaddiction pharmacotherapeutic targeting the receptor type protein tyrosine phosphatase D.

George R UhlPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.